Bone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of Hemochromatosis

Gastroenterology

Volumn 137, Issue 4, 2009, Pages 1489-1497

  Corradini, Elena ^a,b   Garuti, Cinzia ^b   Montosi, Giuliana ^b   Ventura, Paolo ^b   Andriopoulos Jr , Billy ^a   Lin, Herbert Y ^a   Pietrangelo, Antonello ^b   Babitt, Jodie L ^a  

^a Center for Systems Biology   (United States)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 6; HEPCIDIN; HFE PROTEIN; IRON; MESSENGER RNA; SMAD PROTEIN; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HEMOCHROMATOSIS; IRON METABOLISM; LIVER CELL; LIVER LEVEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS REGULATION; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BONE MORPHOGENETIC PROTEIN 6; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; INHIBITOR OF DIFFERENTIATION PROTEIN 1; IRON, DIETARY; LIVER; MALE; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN;

EID: 70349494083     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.06.057     Document Type: Article

References (49)

1. Pietrangelo A. Hereditary hemochromatosis-a new look at an old disease. N Engl J Med 350 (2004) 2383-2397
2. Merryweather-Clarke A.T., Pointon J.J., Shearman J.D., et al. Global prevalence of putative haemochromatosis mutations. J Med Genet 34 (1997) 275-278
3. Zhou X.Y., Tomatsu S., Fleming R.E., et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci U S A 95 (1998) 2492-2497
4. Levy J.E., Montross L.K., Cohen D.E., et al. The C282Y mutation causing hereditary hemochromatosis does not produce a null allele. Blood 94 (1999) 9-11
5. Bahram S., Gilfillan S., Kühn L.C., et al. Experimental hemochromatosis due to MHC class I HFE deficiency: immune status and iron metabolism. Proc Natl Acad Sci U S A 96 (1999) 13312-13317
6. Feder J.N., Gnirke A., Thomas W., et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13 (1996) 399-408
7. Feder J.N., Tsuchihashi Z., Irrinki A., et al. The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression. J Biol Chem 272 (1997) 14025-14028
8. Waheed A., Parkkila S., Zhou X.Y., et al. Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci U S A 94 (1997) 12384-12389
9. Parkkila S., Waheed A., Britton R.S., et al. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci U S A 94 (1997) 13198-13202
10. Feder J.N., Penny D.M., Irrinki A., et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci U S A 95 (1998) 1472-1477
11. Waheed A., Parkkila S., Saarnio J., et al. Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum. Proc Natl Acad Sci U S A 96 (1999) 1579-1584
12. Lebrón J.A., West Jr. A.P., and Bjorkman P.J. The hemochromatosis protein HFE competes with transferrin for binding to the transferrin receptor. J Mol Biol 294 (1999) 239-245
13. Bennett M.J., Lebrón J.A., and Bjorkman P.J. Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor. Nature 403 (2000) 46-53
14. West Jr. A.P., Giannetti A.M., Herr A.B., et al. Mutational analysis of the transferrin receptor reveals overlapping HFE and transferrin binding sites. J Mol Biol 313 (2001) 385-397
15. Giannetti A.M., and Björkman P.J. HFE and transferrin directly compete for transferrin receptor in solution and at the cell surface. J Biol Chem 279 (2004) 25866-25875
16. Goswami T., and Andrews N.C. Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J Biol Chem 281 (2006) 28494-28498
17. Chen J., Chloupkova M., Gao J., et al. HFE modulates transferrin receptor 2 levels in hepatoma cells via interactions that differ from transferrin receptor 1-HFE interactions. J Biol Chem 282 (2007) 36862-36870
18. Vujic Spasic M., Kiss J., Herrmann T., et al. Hfe acts in hepatocytes to prevent hemochromatosis. Cell Metab 7 (2008) 173-178
19. Ahmad K.A., Ahmann J.R., Migas M.C., et al. Decreased liver hepcidin expression in the Hfe knockout mouse. Blood Cells Mol Dis 29 (2002) 361-366
20. Nicolas G., Viatte L., Lou D.Q., et al. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat Genet 34 (2003) 97-101
21. Muckenthaler M., Roy C.N., Custodio A.O., et al. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis. Nat Genet 34 (2003) 102-107
22. Bridle K.R., Frazer D.M., Wilkins S.J., et al. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361 (2003) 669-673
23. Piperno A., Girelli D., Nemeth E., et al. Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis. Blood 110 (2007) 4096-4100
24. Pigeon C., Ilyin G., Courselaud B., et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276 (2001) 7811-7819
25. Krause A., Neitz S., Magert H.J., et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480 (2001) 147-150
26. Park C.H., Valore E.V., Waring A.J., et al. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276 (2001) 7806-7810
27. Nemeth E., Tuttle M.S., Powelson J., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306 (2004) 2090-2093
28. Schmidt P.J., Toran P.T., Giannetti A.M., et al. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metab 7 (2008) 205-214
29. Gao J., Chen J., Kramer M., et al. Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression. Cell Metab 9 (2009) 217-227
30. Papanikolaou G., Samuels M.E., Ludwig E.H., et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 36 (2004) 77-82
31. Babitt J.L., Huang F.W., Wrighting D.M., et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 38 (2006) 531-539
32. Babitt J.L., Huang F.W., Xia Y., et al. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J Clin Invest 117 (2007) 1933-1939
33. Shi Y., and Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113 (2003) 685-700
34. Miyazono K., and Miyazawa K. Id: a target of BMP signaling. Sci STKE 2002 (2002) PE40
35. Korchynskyi O., and Ten Dijke P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem 277 (2002) 4883-4891
36. Wang R.H., Li C., Xu X., et al. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab 2 (2005) 399-409
37. Truksa J., Peng H., Lee P., et al. Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc Natl Acad Sci U S A 103 (2006) 10289-10293
38. Truksa J., Peng H., Lee P., et al. Different regulatory elements are required for response of hepcidin to interleukin-6 and bone morphogenetic proteins 4 and 9. Br J Haematol 139 (2007) 138-147
39. Verga Falzacappa M.V., Casanovas G., Hentze M.W., et al. A bone morphogenetic protein (BMP)-responsive element in the hepcidin promoter controls HFE2-mediated hepatic hepcidin expression and its response to IL-6 in cultured cells. J Mol Med 86 (2008) 531-540
40. Yu P.B., Hong C.C., Sachidanandan C., et al. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol 4 (2008) 33-41
41. Andriopoulos Jr. B., Corradini E., Xia Y., et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet 41 (2009) 482-487
42. Huang F.W., Pinkus J.L., Pinkus G.S., et al. A mouse model of juvenile hemochromatosis. J Clin Invest 115 (2005) 2187-2191
43. Niederkofler V., Salie R., and Arber S. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J Clin Invest 115 (2005) 2180-2186
44. Meynard D., Kautz L., Darnaud V., et al. Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet 41 (2009) 478-481
45. Kautz L., Meynard D., Monnier A., et al. Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood 112 (2008) 1503-1509
46. Torrance J.D., and Bothwell T.H. Tissue iron stores. In: Cook J.D. (Ed). Methods in hematology Volume 1 (1980), Churchill Livingstone, New York 90-115
47. Montosi G., Corradini E., Garuti C., et al. Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload. Hepatology 41 (2005) 545-552
48. Gehrke S.G., Herrmann T., Kulaksiz H., et al. Iron stores modulate hepatic hepcidin expression by an HFE-independent pathway. Digestion 72 (2005) 25-32
49. Xia Y., Babitt J.L., Sidis Y., et al. Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin. Blood 111 (2008) 5195-5204